hsa-mir-1468: Hsa-mir-1468 is a differentially expressed microRNA (miRNA) that has been identified in various studies. It is upregulated in conditions such as acute myocardial infarction (AMI) [PMC8923688], cattle genome [PMC2713767], and lung adenocarcinoma [PMC6208346]. It is also associated with poor overall survival in pancreatic adenocarcinoma [PMC9158148]. Hsa-mir-1468 has a high purine content, along with other miRNAs such as hsa-mir-765 and hsa-mir-1910 [PMC9316571]. In addition, it has been found to be negatively correlated with the expression of target genes and poor overall survival in various cancers, including hepatocellular carcinoma and epithelial ovarian cancer [PMC6208346]. Hsa-mir-1468 is also implicated in the regulation of mRNA expression of PIP4K2A, which is associated with paclitaxel resistance and worse overall survival in small cell lung cancer patients [PMC7798616][PMC3573965]. Furthermore, it has been used as a biomarker to distinguish steroid-resistant acute severe ulcerative colitis patients with high accuracy [PMC8298863]. Overall, hsa-mir-1468 plays a role in various biological processes and has potential clinical implications.